- This event has passed.
JOHNSON & JOHNSON INNOVATION – JLABS INFORMATIONAL SESSION & BREAKOUTS
July 13, 2022 @ 12:00 pm - 1:00 pm
What does it take to apply for a JLABS virtual residency? Find out!
- July 13, virtual
- Information session at noon
- Breakouts beginning at 1 p.m., by appointment
- SIGN UP
New wet and dry labs will be opening soon at the Virginia Tech Corporate Research Center. In addition to labs in Blacksburg, VTCRC is collaborating with Johnson & Johnson LLC, to provide early-stage innovators in the region with access to their virtual residency program which includes expert mentoring, programming and resources offered through Johnson & Johnson Innovation – JLABS (JLABS). JLABS was established in 2012 to provide startups with access to the critical resources, expertise, networks, and collaborations needed to progress innovative healthcare solutions for patients and consumers.
The collaboration aims to meet the needs of emerging startups and existing biotech companies in the region. In the first year of the collaboration, JLABS and the VTCRC will select up to five companies for participation in the JLABS virtual residency program. The application period will open early 2022.
But what does it take to apply for a JLABS virtual residency?
Dr. Michael Nestor, Scientific Engagement Lead for JLABS @ Washington, DC, will lead a talk to help you better understand the program, how to apply, and what it takes to submit a qualifying application. He’ll help you understand how the Innovation Centers interact with early stage companies and how they can prepare themselves for a potential successful collaboration with Johnson & Johnson Innovation.
ABOUT THE SPEAKER
Dr. Michael Nestor is responsible for external engagement with regional academic research institutions, start-ups, investment partners and portfolio management.
He received his PhD in Neuroscience from the University of Maryland, School of Medicine where he was trained as an electrophysiologist and completed postdoctoral fellowships at the National Institutes of Health and The New York Stem Cell Foundation, where he was also a Staff Scientist. Michael was also an AAAS Science & Technology Policy Fellow and a NIH IRACDA Fellow at Rutgers University where he focused on teaching in minority-serving institutions increasing the participation of traditionally underrepresented groups in science.
Nestor was Director of Neural Stem Cell Research at The Hussman Institute for Autism where he led his own group studying autism by creating brain organoids from human induced pluripotent stem cells. His lab developed a multiplexed high-throughput CRISPR and drug-screening platform. Nestor also served as Co-Chair of the Neural Stem Cell Working Group at the University of Maryland, School of Medicine and as a venture advisor to the UM Momentum Fund and the Abell Foundation. He also ran his own human stem cell consulting company, Synapstem.
